The company is building a new facility next to its existing research labs. The update on its investment plans came alongside ...

AstraZeneca is building a US$1.5 billion manufacturing facility in Tuas South, Singapore, which will create over 800 jobs.

The executive in charge of AstraZeneca operations in China is under detention by Chinese authorities who are investigating employees there, the company said. The disclosure comes after AstraZeneca ...

Researchers have found a new way to use biocatalysis to improve the production of critical raw materials required for ...

British drug maker AstraZeneca Plc (AZN.L, AZN) announced Tuesday positive data from global KOMET Phase III trial, in which Koselugo ...

AstraZeneca may be emphasizing the potential for combination treatments to help its obesity pipeline stand out from the crowd, but the Big Pharma insists it is still “playing to win” in the space.

Over the past three years, additional insurance fraud cases have emerged involving AstraZeneca employees in various Chinese regions. The investigation focuses on potential breaches of data privacy ...

Apart from its pill, Viking is developing a weight loss injection and other treatments. Meanwhile, AstraZeneca said its ...

In 2015, the United Nations outlined 17 Sustainable Development Goals (SDGs) aimed at eradicating poverty, protecting our ...

AstraZeneca Plc said its experimental obesity pill was well tolerated by patients with type-2 diabetes as it presented data from several studies testing its three new weight-loss medicines. The ...

Pascal Soriot, CEO of AstraZeneca, said the growth in total revenue and core earnings per share reflected the "increasing ...